EDUCATIONAL TOOL ONLY. Not legal or medical advice. Not affiliated with the VA.
← All Condition GuidesCLAIM RECON INTEL
Chronic NSAID Use
DC 6299 | 38 CFR § 3.310 (secondary service connection) |
Chronic NSAID Use is rated by the U.S. Department of Veterans Affairs under DC 6299 of 38 CFR § 3.310 (secondary service connection) across 3 severity tiers (40%+ -- Severe limitation or ankylosis / 20% -- Moderate limitation / 10% -- Mild limitation or painful motion). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303. This condition is frequently rated as secondary to GERD or Peptic Ulcer Disease under 38 C.F.R. § 3.310.
OVERVIEW
Long-term use of nonsteroidal anti-inflammatory drugs (ibuprofen, naproxen, meloxicam, celecoxib, diclofenac) prescribed to treat service-connected musculoskeletal or other painful conditions. Documented side effects — peptic ulcer disease (DC 7304 consolidation per § 4.114), gastritis (rate as DC 7304), GERD (DC 7203 per § 4.114 amendment), chronic kidney disease, NSAID-induced hypertension, and increased cardiovascular events — are eligible for secondary service connection under 38 CFR § 3.310 when the underlying pain condition is service-connected.
RATING CRITERIA (3 LEVELS)
40%+ -- Severe limitation or ankylosis
Severe limitation of motion or ankylosis of the affected joint. Specific percentages depend on the joint and whether dominant/non-dominant.
20% -- Moderate limitation
Moderate limitation of motion with significant functional impairment. DeLuca factors may increase the effective rating.
10% -- Mild limitation or painful motion
Mild limitation of motion, or X-ray evidence of arthritis with painful motion under DC 5003.
KEY EVIDENCE TO GATHER
-Service treatment records showing injury or complaints
-Imaging (X-ray, MRI, CT)
-Range of motion measurements
-Flare-up documentation per Sharp v. Shulkin
-Buddy statements describing limitations
-Prescription history
-Physical therapy records
-Employment impact documentation
SECONDARY CONDITIONS (6 MAPPED)
DC
NSAIDs reduce protective stomach mucus leading to acid reflux
DC
NSAIDs inhibit prostaglandins needed for stomach lining protection
DC
NSAIDs reduce kidney blood flow causing progressive damage
DC
NSAIDs cause sodium retention and vasoconstriction
DC
Mucosal damage leads to hemorrhage
DC
Hepatotoxicity from chronic use
C&P EXAM TIPS (6)
1.Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.
2.Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.
3.Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.
4.Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).
5.If you use assistive devices (brace, cane), bring them.
6.Describe daily activity impact: work, sleep, household tasks.
SOURCES & EDITORIAL
Rating criteria reference 38 C.F.R. Part 4 (Schedule for Rating Disabilities). This entry has not yet undergone editorial review against the live regulation text — consult the authoritative source directly before relying on the criteria shown.
EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026